C12Y 201/01001
Nicotinamide n-methyltransferase
Official title: Nicotinamide N-methyltransferase (2.1.1.1)
C12Y201/01001 (Nicotinamide n-methyltransferase) appears on 3 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 4
- Assignees
- 5
- Inventors
- 16
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- RNA programmable epigenetic RNA modifiers and uses thereof13 Jan 2026US 12,522,807 B2President and Fellows of Harvard College
- Pharmaceutical composition for treating chronic kidney disease2 Oct 2018US 10,087,449 B2Keio University
- Methods of treating obesity by inhibiting nicotinamide N-methyl transferase (NNMT)7 Jul 2015US 9,072,766 B2Beth Israel Deaconess Medical Center, Inc.
- Rna programmable epigenetic rna modifiers and uses thereof19 Mar 2026US 2026/0078355 A1President and Fellows of Harvard College
- Rna programmable epigenetic rna modifiers and uses thereof3 Feb 2022US 2022/0033785 A1President and Fellows of Harvard College
- Pharmaceutical composition for treating chronic kidney disease20 Apr 2017US 2017/0107521 A1Keio University
- Methods Of Treating Obesity By Inhibiting Nicotinamide N-Methyl Transferase (NNMT)19 Sep 2013US 2013/0243790 A1Beth Israel Deaconess Medical Center, Inc.
Most cited
By later US patents
- Methods of treating obesity by inhibiting nicotinamide N-methyl transferase (NNMT)5US 9,072,766 B2Beth Israel Deaconess Medical Center, Inc. · 2015
- Pharmaceutical composition for treating chronic kidney disease1US 10,087,449 B2Keio University · 2018
- RNA programmable epigenetic RNA modifiers and uses thereof1US 12,522,807 B2President and Fellows of Harvard College · 2026